Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2008
02/14/2008US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
02/14/2008US20080039429 Sulfonylethyl phosphorodiamidates
02/14/2008US20080039427 Method and compositions for treating hematological malignancies
02/14/2008US20080039426 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease
02/14/2008US20080038466 Tantalum and niobium compounds and their use for chemical vapour deposition (cvd)
02/14/2008DE102006037955A1 Tantal- und Niob-Verbindungen und ihre Verwendung für die Chemical Vapour Deposition (CVD) Tantalum and niobium compounds and their use for the chemical vapor deposition (CVD)
02/14/2008CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
02/13/2008EP1887012A2 Organometallic compounds for chemical vapour deposition and atomic layer deposition of thin films
02/13/2008EP1887011A1 Alpha amino acid phosphonic acid compounds, method of preparation and use thereof
02/13/2008EP1885732A2 CHIRAL DIPHOSPHONITES AS LIGANDS IN THE RUTHENIUM-CATALYSED ENANTIOSELECTIVE REDUCTION OF KETONES ß-KETO-ESTERS AND KETIMINES
02/13/2008EP1885694A2 4-biarylyl-1-phenylazetidin-2-ones
02/13/2008EP1885369A2 Fused heterocyclic compounds, and compositions and uses thereof
02/13/2008EP1805107A4 Process for the preparation of highly purified, dialkyl phosphinic acids
02/13/2008EP1774331A4 Cytoxan antibodies and immunoassay
02/13/2008EP1747205A4 Pharmaceutical compositions
02/13/2008EP1313703B1 Prodrugs to nmda receptor ligands
02/13/2008EP1233770B1 Phosphonate compounds
02/13/2008CN101124234A Catalyst for asymmetric synthesis, ligand used therefor and method for producing optically active compound by asymmetric synthetic reaction using the same
02/13/2008CN101121734A Organometallic compounds
02/13/2008CN101121733A Organometallic compounds
02/13/2008CN101121730A Phosphaalkene ligand and its preparing method and use
02/13/2008CN101121729A 5,5'-position connected 1,1'-biphenyl axis chirality diphosphine ligand and synthetic method thereof
02/12/2008US7329778 Oxidation catalyst for forming acid salt from alcohol
02/12/2008US7329768 Chemical vapor deposition precursors for deposition of tantalum-based materials
02/12/2008US7329762 Prodrugs of mitotic kinesin inhibitors
02/12/2008CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
02/07/2008WO2008016692A2 Chemical compounds
02/07/2008WO2008016674A1 Agonists of the sphingosine- 1- phosphate receptor (slp)
02/07/2008WO2008015322A1 Process for preparing materials by grafting halogenated phosphorus groups onto an inorganic surface
02/07/2008WO2008015081A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
02/07/2008WO2007131498A3 Salts consisting of pentafluorphenylimide anions and their use as ionic liquids
02/07/2008WO2006136564A9 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
02/07/2008US20080033197 Oxathiazaphospholidine free radical control agent
02/07/2008US20080033178 Ionic Liquids
02/07/2008US20080033176 Method for preparing prostaglandin derivative
02/07/2008US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
02/07/2008US20080032951 Ophthalmic Compositions For Treating Ocular Hypertension
02/07/2008US20080032950 Neurologically-Active Compounds
02/07/2008US20080032949 Embedded Biocide
02/07/2008CA2659473A1 Chemical compounds
02/07/2008CA2658797A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
02/06/2008EP1884519A1 Metal hydride complex, method of hydrogenating ring-opening polymerization polymer of cycloolefin, and process for producing product of hydrogenation of ring-opening polymerization polymer of cycloolefin
02/06/2008EP1884518A1 Metal-imino complexes suitable for use as vapor deposition precursors
02/06/2008EP1884517A1 Organometallic compounds containing an alkenyl ligand and suitable for use as vapor deposition precursors
02/06/2008EP1884509A1 Optically active 3-methylcyclopentadecanone and method for producing intermediate thereof
02/06/2008EP1883645A1 Derivatives of 4-or 5-aminosalicylic acid
02/06/2008EP1883644A2 Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof
02/06/2008EP1883643A1 Fluorinated organic silicon coating material
02/06/2008EP1883471A2 Processes for recovery of a triarylphosphine from a group viii metal catalyst complex mixture
02/06/2008EP1845981A4 Synthesis of sodium narcistatin and related compounds
02/06/2008CN101120009A Recovery of noble metals from aqueous process streams in the synthesis of glyphosate using adsorption media such as ion exchange resins
02/06/2008CN101120008A Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans
02/06/2008CN101117580A Tris(nonyl)phosphate anti-oxidant and preparation method thereof
02/06/2008CN101117405A Method for preparing non-toxicity organophosphorus ester flame-proof plasticizing agent
02/06/2008CN101117339A Method for preparing sodium ibandronate crystal and hydrated crystal thereof
02/06/2008CN100366627C Method for producing organic compounds contg poly-dopo, and use of the same
02/06/2008CN100366626C High boiling inhibitors for distillable, polymerizable monomers
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/05/2008US7326801 2-amino-propanol derivatives
02/05/2008CA2205406C Novel benzyl pyrimidines
02/05/2008CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof
01/2008
01/31/2008WO2008014510A2 Crystalline form a of ibandronic acid and process for the preparation
01/31/2008WO2008014286A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists
01/31/2008WO2008014139A2 Olefin oligomerization catalysts and methods of using same
01/31/2008WO2008013213A1 Prodrug of cinnamide compound
01/31/2008WO2008012953A1 Alkylation composition, and method for detoxification of toxic compound using the composition
01/31/2008WO2008012950A1 Composition for alkylation, and method for detoxification of toxic compound using the composition
01/31/2008WO2008012935A1 Alkylation composition, and method for detoxification of toxic compound using the composition
01/31/2008WO2008012298A1 White electroluminescent organic diodes based on molecules derived from phosphole.
01/31/2008WO2007143175A3 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer
01/31/2008WO2007123957A3 Bisphospholanes for use as catalysts in asymmetric reactions
01/31/2008US20080027239 Process For The Racemoselective Synthesis Of Ansa-Metallocenes
01/31/2008US20080027230 reacting an onium chloride with an acid resulting in formation of hydrochloric acid, formed hydrochloric acid is removed by azeotropic distillation by coordination to 1,4-dioxane which forms an azeotropic mixture with water;
01/31/2008US20080027195 Preparing 1,3-bis(2,6-dimethylphenyl)-iminoimidazoline cyclopentadienyl titanium dimethyl, tris(N,N-dimethylamido)phosphoraneimido cyclopentadienyl titanium(IV) dichloride or the like; reacting phosphorimidic triamide, aminophosphonium chloride, or iminoimidazoline with group IV or V compound in base
01/31/2008US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics
01/31/2008US20080027029 Cold menthol receptor-1 antagonists
01/31/2008US20080026966 Process for Producing Zinc Dialkyldithiophosphates Exhibiting Improved Seal Compatibility Properties
01/31/2008DE102004029698B4 Nickelkomplexe von 2-Amino- und 2-Hydroxy-2-phosphinoalkansäure-Derivaten, Verfahren zur Herstellung dieser Nickelkomplexe und deren Verwendung als Katalysatoren zur Oligomerisation bzw. Polymerisation von Olefinen Nickel complexes of 2-amino and 2-hydroxy-2-phosphinoalkansäure derivatives, processes for preparing these nickel complexes and their use as catalysts for oligomerization and polymerization of olefins
01/31/2008CA2658908A1 White electroluminescent organic diodes based on molecules derived from phosphole
01/31/2008CA2658037A1 Prodrug of cinnamide compound
01/31/2008CA2657157A1 Olefin oligomerization catalysts and methods of using same
01/30/2008EP1882695A2 Pharmaceutically active compounds and methods of use thereof
01/30/2008EP1882694A1 Thiophene compound having phosphoric ester and process for producing the same
01/30/2008CN101115761A Prodrugs of 2,4-pyrimidinediamine compounds and their uses
01/30/2008CN101115738A Pyrazolylamino substituted quinazoles for the treatment of cancer
01/30/2008CN100365038C Curing agent for epoxide resins, use thereof and cured epoxide resin therewith
01/30/2008CN100365004C Method for producing acylphosphine oxide solids
01/30/2008CN100365003C Esters of phosphorus-oxygen acids, these esters comprising alkoxy groups, and their use as corrosion inhibitors and flameproofing agents
01/30/2008CN100365002C Process for preparing fotemustine for injection
01/30/2008CN100365001C Synthesis method of 3-amino propylomine ethyl thio phosphoric acid
01/30/2008CN100365000C Combretastatin A-4 as phosphorylcholine precursor medicine and its synthesis and application
01/29/2008US7323601 Enanitomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics
01/29/2008US7323572 Freeze-drying, reducing the temperature in the apparatus to bring about freezing and eutectic solidification, reducing the pressure in the apparatus to below the saturation vapour pressure of water over ice, sublimation
01/29/2008US7323449 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus
01/29/2008US7323119 by using phosphite compounds containing the bis-cyclic structure of spiro phosphites, both rings being attached to the same tertiary carbon atom in the phosphite molecule; protect against discoloration for prolonged usage
01/24/2008WO2008010430A1 Phosphorus-containing benzoxazine compound, process for production thereof, curable resin composition, cured article, and laminate plate
01/24/2008WO2008010429A1 Phosphorus-containing benzoxazine compound, process for production thereof, curable resin composition, cured article, and laminate plate
01/24/2008WO2007136650A3 Method and compositions for treating hematological malignancies
01/24/2008US20080021245 Process for recovering phosphorus ligands from metal complexes having phosphine ligands
01/24/2008US20080021005 Pegylated Ion Channel Modulating Compounds